Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats

Neuropharmacology

Volumn 47, Issue SUPPL. 1, 2004, Pages 256-273

  Barrett, Andrew C ^a   Miller, John R ^a   Dohrmann, Jennifer M ^a   Caine, S Barak ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

Animal model; Cocaine; Dopamine; Pharmacotherapy; Rat; Self administration

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; COCAINE; DEXAMPHETAMINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; ECOPIPAM; ETICLOPRIDE; QUINELORANE; VANOXERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; COCAINE DEPENDENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; FOOD; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

EID: 4644357751     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2004.07.007     Document Type: Article

References (87)

1. Barrett R.L., Appel J.B. Effects of stimulation and blockade of dopamine receptor subtypes on the discriminative stimulus properties of cocaine. Psychopharmacology (Berl). 99:1989;13-16
2. Bergman J., Madras B.K., Johnson S.E., Spealman R.D. Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J. Pharmacol. Exp. Ther. 251:1989;150-155
3. Bergman J., Kamien J.B., Spealman R.D. Antagonism of cocaine self-administration by selective dopamine D(1) and D(2) antagonists. Behav. Pharmacol. 1:1990;355-363
4. Bergman J., Rosenzweig-Lipson S., Spealman R.D. Differential effects of dopamine D1 and D2 receptor agonists on schedule-controlled behavior of squirrel monkeys. J. Pharmacol. Exp. Ther. 273:1995;40-48
5. Birmingham A.M., Nader S.H., Grant K.A., Davies H.M., Nader M.A. Further evaluation of the reinforcing effects of the novel cocaine analog 2beta-propanoyl-3beta-(4-tolyl)-tropane (PTT) in rhesus monkeys. Psychopharmacology (Berl). 136:1998;139-147
6. Britton D.R., Curzon P., Mackenzie R.G., Kebabian J.W., Williams J.E., Kerkman D. Evidence for involvement of both D1 and D2 receptors in maintaining cocaine self-administration. Pharmacol. Biochem. Behav. 39:1991;911-915
7. Caine S.B., Koob G.F. Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. Science. 260:1993;1814-1816
8. Caine S.B., Koob G.F. Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J. Pharmacol. Exp. Ther. 270:1994;209-218
9. Caine S.B., Koob G.F. Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat. Behav. Pharmacol. 6:1995;333-347
10. Caine S.B., Ralph-Williams R.J. Behavioral pharmacologists, don't just say "no" to knockout mice. Commentary on Stephens et al. 'Studying the neurobiology of stimulant and alcohol abuse and dependence in genetically manipulated mice'. Behav. Pharmacol. 13:2002;349-352
11. Caine, S.B., Lintz, R., Koob, G.F., 1993. Intravenous drug self-administration techniques in animals. In: Sahgal, A., (Ed.), Behavioral Neuroscience: a practical approach. IRL Press at Oxford University Press, Oxford, pp. 117-143.
12. Caine S.B., Negus S.S., Mello N.K., Bergman J. Effects of dopamine D(1-like) and D(2-like) agonists in rats that self-administer cocaine. J. Pharmacol. Exp. Ther. 291:1999;353-360
13. Caine S.B., Negus S.S., Mello N.K. Effects of dopamine D(1-like) and D(2-like) agonists on cocaine self-administration in rhesus monkeys, rapid assessment of cocaine dose-effect functions. Psychopharmacology (Berl). 148:2000;41-51
14. Caine S.B., Negus S.S., Mello N.K., Bergman J. Effects of dopamine D1-like and D2-like agonists in rats trained to discriminate cocaine from saline, influence of experimental history. Exp. Clin. Psychopharmacol. 8:2000;404-414
15. Caine S.B., Gabriel K.I., Berkowitz J.S., Zhang J., Xu M. Decreased cocaine self-administration in dopamine D-1 receptor knockout mice. Drug Alcohol Depend. 66:2002;S25
16. Caine S.B., Negus S.S., Mello N.K., Patel S., Bristow L., Kulagowski J., Vallone D., Saiardi A., Borrelli E. Role of dopamine D2-like receptors in cocaine self-administration, studies with D2 receptor mutant mice and novel D2 receptor antagonists. J. Neurosci. 22:2002;2977-2988
17. Callahan P.M., Cunningham K.A. Discriminative stimulus properties of cocaine in relation to dopamine D2 receptor function in rats. J. Pharmacol. Exp. Ther. 266:1993;585-592
18. Callahan P.M., Appel J.B., Cunningham K.A. Dopamine D1 and D2 mediation of the discriminative stimulus properties of D-amphetamine and cocaine. Psychopharmacology (Berl). 103:1991;50-55
19. Charnaud B., Griffiths V. Levels of intravenous drug misuse among clients prescribed oral dextroamphetamine or oral methadone, a comparison. Drug Alcohol Depend. 52:1998;79-84
20. Dworkin S.I., Lambert P., Sizemore G.M., Carroll F.I., Kuhar M.J. RTI-113 administration reduces cocaine self-administration at high occupancy of dopamine transporter. Synapse. 30:1998;49-55
21. Evans S.M., Walsh S.L., Levin F.R., Foltin R.W., Fischman M.W., Bigelow G.E. Effect of flupenthixol on subjective and cardiovascular responses to intravenous cocaine in humans. Drug Alcohol Depend. 64:2001;271-283
22. Fleming P.M., Roberts D. Is the prescription of amphetamine justified as a harm reduction measure? J. R. Soc. Health. 114:1994;127-131
23. Glowa J.R., Wojnicki F.H., Matecka D.D.B.J., Mansbach R.S., Balster R.L., Rice K.C. Effects of dopamine reuptake inhibitors on food- and cocaine-maintained responding, I. Dependence on unit dose of cocaine. Exp. Clin. Psychopharmacol. 3:1995;219-231
24. Glowa J.R., Fantegrossi W.E., Lewis D.B., Matecka D., Rice K.C., Rothman R.B. Sustained decrease in cocaine-maintained responding in rhesus monkeys with 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-hydroxy-3-phenylpropyl) piperazinyl decanoate, a long-acting ester derivative of GBR 12909. J. Med. Chem. 39:1996;4689-4691
25. Grabowski J., Rhoades H., Silverman P., Schmitz J.M., Stotts A., Creson D., Bailey R. Risperidone for the treatment of cocaine dependence, randomized, double-blind trial. J. Clin. Psychopharmacol. 20:2000;305-310
26. Grabowski J., Rhoades H., Schmitz J., Stotts A., Daruzska L.A., Creson D., Moeller F.G. Dextroamphetamine for cocaine-dependence treatment, a double-blind randomized clinical trial. J. Clin. Psychopharmacol. 21:2001;522-526
27. Grech D.M., Spealman R.D., Bergman J. Self-administration of D1 receptor agonists by squirrel monkeys. Psychopharmacology (Berl). 125:1996;97-104
28. Griffiths R.R., Wurster R.M., Brady J.V. Discrete-trial choice procedure: effects of naloxone and methadone on choice between food and heroin. Pharmacol. Rev. 27:1976;357-365
29. Haney M., Ward A.S., Foltin R.W., Fischman M.W. Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans. Psychopharmacology (Berl). 155:2001;330-337
30. Herling S., Woods J.H. Chlorpromazine effects on cocaine reinforced responding in rhesus monkeys: reciprocal modification of rate-altering effects of the drugs. J. Pharmacol. Exp. Ther. 214:1980;354-361
31. Howell L.L., Byrd L.D. Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey. J. Pharmacol. Exp. Ther. 258:1991;178-185
32. Howell L.L., Czoty P.W., Kuhar M.J., Carrol F.I. Comparative behavioral pharmacology of cocaine and the selective dopamine uptake inhibitor RTI-113 in the squirrel monkey. J. Pharmacol. Exp. Ther. 292:2000;521-529
33. Hubner C.B., Moreton J.E. Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat. Psychopharmacology (Berl). 105:1991;151-156
34. Katz J.L., Witkin J.M. Selective effects of the D1 dopamine receptor agonist, SKF38393, on behavior maintained by cocaine injection in squirrel monkeys. Psychopharmacology (Berl). 109:1992;241-244
35. Khroyan T.V., Barrett-Larimore R.L., Rowlett J.K., Spealman R.D. Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior, effects of selective antagonists and agonists. J. Pharmacol. Exp. Ther. 294:2000;680-687
36. Khroyan T.V., Platt D.M., Rowlett J.K., Spealman R.D. Attenuation of relapse to cocaine seeking by dopamine D1 receptor agonists and antagonists in non-human primates. Psychopharmacology (Berl). 168:2003;124-131
37. Kleven M.S., Anthony E.W., Woolverton W.L. Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. J. Pharmacol. Exp. Ther. 254:1990;312-317
38. Koob G.F. Drugs of abuse, anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13:1992;177-184
39. Koob G.F., Caine S.B. Cocaine addiction therapy - are we partially there? Nat. Med. 5:1999;993-995
40. Koob G.F., Le H.T., Creese I. The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat. Neurosci. Lett. 79:1987;315-320
41. Lamas X., Negus S.S., Nader M.A., Mello N.K. Effects of the putative dopamine D3 receptor agonist 7-OH-DPAT in rhesus monkeys trained to discriminate cocaine from saline. Psychopharmacology (Berl). 124:1996;306-314
42. Lile J.A., Wang Z., Woolverton W.L., France J.E., Gregg T.C., Davies H.M., Nader M.A. The reinforcing efficacy of psychostimulants in rhesus monkeys, the role of pharmacokinetics and pharmacodynamics. J. Pharmacol. Exp. Ther. 307:2003;356-366
43. Lynch W.J., Heaser W.A., Carroll M.E. Effects of amphetamine, butorphanol, and morphine pretreatment on the maintenance and reinstatement of cocaine-reinforced responding. Exp. Clin. Psychopharmacol. 6:1998;255-263
44. McKearney J.W. Effects of D-amphetamine, morphine and chlorpromazine on responding under fixed-interval schedules of food presentation or electric shock presentation. J. Pharmacol. Exp. Ther. 190:1974;141-153
45. McKearney J.W. Effects of dopamine uptake inhibitors on schedule-controlled behavior in the squirrel monkey. Psychopharmacology (Berl). 78:1982;377-379
46. Mello N.K., Negus S.S. Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology. 14:1996;375-424
47. Melia K.F., Spealman R.D. Pharmacological characterization of the discriminative-stimulus effects of GBR 12909. J. Pharmacol. Exp. Ther. 258:1991;626-632
48. Mutschler N.H., Bergman J. Effects of chronic administration of the D1 receptor partial agonist SKF77434 on cocaine self-administration in rhesus monkeys. Psychopharmacology (Berl). 160:2002;362-370
49. Nader M.A., Mach R.H. Self-administration of the dopamine D3 agonist 7-OH-DPAT in rhesus monkeys is modified by prior cocaine exposure. Psychopharmacology (Berl). 125:1996;13-22
50. Nader M.A., Grant K.A., Davies H.M., Mach R.H., Childers S.R. The reinforcing and discriminative stimulus effects of the novel cocaine analog 2beta-propanoyl-3beta-(4-tolyl)-tropane in rhesus monkeys. J. Pharmacol. Exp. Ther. 280:1997;541-550
51. Negus S.S. Rapid assessment of choice between cocaine and food in rhesus monkeys, effects of environmental manipulations and treatment with D-amphetamine and flupenthixol. Neuropsychopharmacology. 28:2003;919-931
52. Negus S.S., Mello N.K. Effects of chronic D-amphetamine treatment on cocaine- and food-maintained responding under a second-order schedule in rhesus monkeys. Drug Alcohol Depend. 70:2003;39-52
53. Negus S.S., Mello N.K., Lamas X., Mendelson J.H. Acute and chronic effects of flupenthixol on the discriminative stimulus and reinforcing effects of cocaine in rhesus monkeys. J. Pharmacol. Exp. Ther. 278:1996;879-890
54. Negus S.S., Brandt M.R., Mello N.K. Effects of the long-acting monoamine reuptake inhibitor indatraline on cocaine self-administration in rhesus monkeys. J. Pharmacol. Exp. Ther. 291:1999;60-69
55. Platt D.M., Rowlett J.K., Spealman R.D. Modulation of cocaine and food self-administration by low- and high-efficacy D1 agonists in squirrel monkeys. Psychopharmacology (Berl). 157:2001;208-216
56. Platt D.M., Rodefer J.S., Rowlett J.K., Spealman R.D. Suppression of cocaine- and food-maintained behavior by the D2-like receptor partial agonist terguride in squirrel monkeys. Psychopharmacology (Berl). 166:2003;298-305
57. Ranaldi R., Pocock D., Zereik R., Wise R.A. Dopamine fluctuations in the nucleus accumbens during maintenance, extinction, and reinstatement of intravenous D-amphetamine self-administration. J. Neurosci. 19:1999;4102-4109
58. Ranaldi R., Wang Z., Woolverton W.L. Reinforcing effects of D2 dopamine receptor agonists and partial agonists in rhesus monkeys. Drug Alcohol Depend. 64:2001;209-217
59. Ritz M.C., Lamb R.J., Goldberg S.R., Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 237:1987;1219-1223
60. Robbins T.W., Everitt B.J. Functions of dopamine in the dorsal and ventral striatum. Seminars in the Neurosciences. 4:1992;119-127
61. Roberts D.C. Self-administration of GBR 12909 on a fixed ratio and progressive ratio schedule in rats. Psychopharmacology (Berl). 111:1993;202-206
62. Roberts D.C., Phelan R., Hodges L.M., Hodges M.M., Bennett B., Childers S., Davies H. Self-administration of cocaine analogs by rats. Psychopharmacology (Berl). 144:1999;389-397
63. Schenk S. Effects of GBR 12909, WIN and indatraline on cocaine self-administration and cocaine seeking in rats. Psychopharmacology (Berl). 160:(428):2002;263-270
64. Schenk S., Partridge B., Shippenberg T.S. U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking. Psychopharmacology (Berl). 144:1999;339-346
65. Self D.W., Stein L. The D1 agonists SKF 82958 and SKF 77434 are self-administered by rats. Brain Res. 582:1992;349-352
66. Self D.W., Barnhart W.J., Lehman D.A., Nestler E.J. Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists. Science. 271:1996;1586-1589
67. Shearer J., Wodak A., Mattick R.P., Van Beek I., Lewis J., Hall W., Dolan K. Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence. Addiction. 96:2001;1289-1296
68. Sinnott R.S., Mach R.H., Nader M.A. Dopamine D2/D3 receptors modulate cocaine's reinforcing and discriminative stimulus effects in rhesus monkeys. Drug Alcohol Depend. 54:1999;97-110
69. Sizemore G.M., Davies H.M., Martin T.J., Smith J.E. Effects of 2beta-propanoyl-3beta-(4-tolyl)-tropane (PTT) on the self-administration of cocaine, heroin, and cocaine/heroin combinations in rats. Drug Alcohol Depend. 73:2004;259-265
70. Skjoldager P., Winger G., Woods J.H. Effects of GBR 12909 and cocaine on cocaine-maintained behavior in rhesus monkeys. Drug Alcohol Depend. 33:1993;31-39
71. Spealman R.D. Dopamine D3 receptor agonists partially reproduce the discriminative stimulus effects of cocaine in squirrel monkeys. J. Pharmacol. Exp. Ther. 278:1996;1128-1137
72. Spealman R.D., Madras B.K., Berman J. Effects of cocaine and related drugs in nonhuman primates II. Stimulant effects on schedule-controlled behavior. J. Pharmacol. Exp. Ther. 251:1989;142-149
73. Spealman R.D., Bergman J., Madras B.K., Melia K.F. Discriminative stimulus effects of cocaine in squirrel monkeys, involvement of dopamine receptor subtypes. J. Pharmacol. Exp. Ther. 258:1991;945-953
74. Stafford D., Rice K.C., Lewis D.B., Glowa J.R. Response requirements and unit dose modify the effects of GBR 12909 on cocaine-maintained behavior. Exp. Clin. Psychopharmacol. 8:2000;539-548
75. Stafford D., LeSage M.G., Rice K.C., Glowa J.R. A comparison of cocaine, GBR 12909, and phentermine self-administration by rhesus monkeys on a progressive-ratio schedule. Drug Alcohol Depend. 62:2001;41-47
76. Tella S.R., Ladenheim B., Andrews A.M., Goldberg S.R., Cadet J.L. Differential reinforcing effects of cocaine and GBR-12909, biochemical evidence for divergent neuroadaptive changes in the mesolimbic dopaminergic system. J. Neurosci. 16:1996;7416-7427
77. Thomsen, M., Caine, S.B., 2004. Chronic intravenous drug self-administration in rats and mice. Curr. Protocols in Neurosci. (in press).
78. Weed M.R., Woolverton W.L. The reinforcing effects of dopamine D1 receptor agonists in rhesus monkeys. J. Pharmacol. Exp. Ther. 275:1995;1367-1374
79. White R. Dexamphetamine substitution in the treatment of amphetamine abuse, an initial investigation. Addiction. 95:2000;229-238
80. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol. Rev. 94:1987;469-492
81. Wise R.A., Murray A., Bozarth M.A. Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats. Psychopharmacology (Berl). 100:1990;355-360
82. Witkin J.M., Nichols D.E., Terry P., Katz J.L. Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections. J. Pharmacol. Exp. Ther. 257:1991;706-713
83. Wojnicki F.H., Glowa J.R. Effects of drug history on the acquisition of responding maintained by GBR 12909 in rhesus monkeys. Psychopharmacology (Berl). 123:1996;34-41
84. Woolverton W.L., Balster R.L. Effects of antipsychotic compounds in rhesus monkeys given a choice between cocaine and food. Drug Alcohol Depend. 8:1981;69-78
85. Woolverton W.L., Johnson K.M. Neurobiology of cocaine abuse. Trends Pharmacol. Sci. 13:1992;193-200
86. Woolverton W.L., Goldberg L.I., Ginos J.Z. Intravenous self-administration of dopamine receptor agonists by rhesus monkeys. J. Pharmacol. Exp. Ther. 230:1984;678-683
87. Woolverton W.L., Hecht G.S., Agoston G.E., Katz J.L., Newman A.H. Further studies of the reinforcing effects of benztropine analogs in rhesus monkeys. Psychopharmacology (Berl). 154:2001;375-382